1. Home
  2. WLKP vs STOK Comparison

WLKP vs STOK Comparison

Compare WLKP & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westlake Chemical Partners LP

WLKP

Westlake Chemical Partners LP

HOLD

Current Price

$19.83

Market Cap

652.0M

Sector

Industrials

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$32.48

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLKP
STOK
Founded
2014
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
652.0M
1.9B
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
WLKP
STOK
Price
$19.83
$32.48
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$31.00
AVG Volume (30 Days)
64.9K
930.2K
Earning Date
10-30-2025
11-04-2025
Dividend Yield
9.54%
N/A
EPS Growth
N/A
N/A
EPS
1.39
0.68
Revenue
$1,133,706,000.00
$205,632,000.00
Revenue This Year
$3.88
$430.24
Revenue Next Year
$12.71
N/A
P/E Ratio
$14.17
$47.31
Revenue Growth
N/A
1128.17
52 Week Low
$17.75
$5.35
52 Week High
$25.04
$38.69

Technical Indicators

Market Signals
Indicator
WLKP
STOK
Relative Strength Index (RSI) 63.97 58.66
Support Level $18.88 $30.17
Resistance Level $19.19 $35.40
Average True Range (ATR) 0.38 2.13
MACD 0.17 0.31
Stochastic Oscillator 86.29 61.10

Price Performance

Historical Comparison
WLKP
STOK

About WLKP Westlake Chemical Partners LP

Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: